50% off Premium Yearly

TSE:L
This summary was created by AI, based on 13 opinions in the last 12 months.
Loblaw Companies Ltd, the largest food and drug retailer in Canada, has been receiving mixed reviews from experts. While its focus on discount banners and the successful integration of Shoppers Drug Mart has improved profitability and revenue growth, some analysts express concerns about its high valuation and competition from Walmart and Costco. The company is seen as a defensive investment due to its strong private label offerings like No Name, which appeal to budget-conscious consumers amid rising food inflation. However, there are warnings that the current growth may not be sustainable in the long term, with opinions suggesting that alternatives like ATD may offer better growth potential. Overall, while Loblaw is perceived positively, its current valuation and competitive strategies remain points of contention among analysts.
A defensive name, the largest food and drug seller in Canada. The CEO has been focusing on No Frills, which has been outperforming, and their private label which boasts wide margins. Shoppers Drug Mart boasts a 30% market share with strong same-store sales growth. SDM locations offer food, which she also likes.
(Analysts’ price target is $69.73)Defensive idea. Should continue to do well. In uncertain times and economic conditions, you want certainty in your portfolio. Dominant grocery and pharmacy retailer in Canada. Surging earnings growth plus very few competitors.
Private label strength is very strong. No Name label does well when consumers hunt for value. Shoppers, with its high margins, is the growth engine. Yield is 0.89%.
Grocers are seeing a fantastic upswing in the technicals, particularly this one. Higher highs and higher lows both daily and weekly. You don't get a chart that's much better.
Likes industries with few competitors, and Canadian grocers are in that space -- can protect margins and revenues. Tracking better than EMP.A, which he also owns.
Follows. Has done exceptionally well over last few years with food inflation. Real catalyst to unlocking profitability was when it acquired Shoppers Drug Mart -- a potent combination. Profitability has improved, generates significant free cashflow. Good business, fairly reasonable valuation. FCF yield is slightly north of 5%. Reasonable investment if you have your heart set.
He prefers ATD.
He's not into staples right now; missed the big run, as this name did very well. Caught up in the noise around tariffs, though its margins have widened a bit (may have "priced in" inflation, but it actually might be the suppliers and distributors taking the hit). That might be working its way out now.
This type of company is less loved by the market because the momentum stocks are doing so well.
Don't fixate too much on bread-fixing issue. Sticky inflation has helped margins. One to hold as a core defensive name in your portfolio. Not particularly overvalued, given all the franchises it encompasses.
For exposure in the space, he's pivoted to a name like ATD. Over the next 12 months he'd bet that ATD, and not Loblaw, would beat expectations.
Stock split doesn't change his view of the fundamentals, which he likes. Leading grocer. Advantaged by all its discount banners, and consumers are gravitating toward these with all the economic uncertainty. Store brands like President's Choice and no name are resonating well. Shoppers DM has high organic growth prospects. Biggest loyalty program in Canada. PC Financial is another good segment.
Likes family-led companies, as they go for the long game.
He wouldn't buy it today. It is expensive with a greater multiple than Metro or Empire. It is low margin business and can be considered a defensive stock. Costco is a great name in the space. The question also asked his opinion on buying it before or after the split. He would probably buy it before.
Loblaw Companies Ltd is a Canadian stock, trading under the symbol L.TO (previously L-T on Stockchase) on the Toronto Stock Exchange (L-CT). It is usually referred to as TSX:L or L.TO
In the last year, 13 stock analysts issued a Buy, Sell, or Hold rating on L.TO (previously L-T on Stockchase). 6 analysts recommended to BUY and 5 analysts recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Loblaw Companies Ltd.
Loblaw Companies Ltd was recommended as a Top Pick by Chris Blumas on 2026-08-12. Read the latest stock experts ratings for Loblaw Companies Ltd.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Loblaw Companies Ltd.
Loblaw Companies Ltd is followed by 322 investors on Stockchase and is a trending stock that is worth watching.
On 2026-08-19, Loblaw Companies Ltd (L.TO) stock closed at a price of $61.79.
Don't buy now, simply because of valuation. Essential business, has done exceptionally well. Discount banners are a positive. Domestic only, so growth outlook can only go so far without doing peripheral acquisitions.
He often compares L to ATD, and the global platform of ATD tilts the odds in its favour.